- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07926529
The Effect of Laughter Therapy on the Quality of Life and Psychological Well-being of Nursing Students
The nursing profession is a healthcare discipline that combines theoretical knowledge with clinical practice skills. The primary aim of nursing education is to train healthcare professionals who are prepared for the profession, aware of their duties and responsibilities, and capable of providing effective care to individuals and the community. During their education, nursing students face various challenges both in the academic sphere and in clinical settings. Students are confronted with numerous stressors, such as a heavy course load, preparing for examinations, undertaking clinical placements, a lack of self-confidence, and the changes brought about by the university environment. When this process is not managed effectively, it is thought that students' quality of life and psychological well-being may be adversely affected. Accordingly, there is a need for complementary health approaches to enhance nursing students' quality of life and to safeguard and promote their psychological well-being. Included among these complementary health approaches, laughter therapy has physiological and psychological effects on individuals. There are numerous positive effects associated with laughter, such as improving cognitive functions, enhancing respiration, increasing pain tolerance, improving sleep quality, reducing exam anxiety and lowering stress hormone levels.
Accordingly, the aim of this thesis is to investigate the effect of laughter therapy administered to nursing students on their quality of life and psychological well-being. A review of the literature revealed no existing studies on this topic. Consequently, it is anticipated that this planned thesis will make a significant contribution to filling this gap in the literature.
The study is planned as a randomised controlled experimental study using a pre-test-post-test-follow-up design. The research will be conducted with second-year nursing students at the Faculty of Health Sciences, Çankırı Karatekin University. A total of 112 students who meet the inclusion criteria and are allocated to the experimental (n=56) and control (n=56) groups via randomisation will form the study sample. Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. Session times will be planned together with the students in the experimental group who will receive laughter therapy. Research data will be collected using the Demographic Information Form, the SF-12 Quality of Life Scale and the Psychological Well-being Scale. IBM SPSS Statistics for Windows, Version 24.0, will be used to analyse the data obtained from this study.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: fahriye s kara
- Numéro de téléphone: +90 539 210 49 71
- E-mail: 248426003@ogrenci.karatekin.edu.tr
Lieux d'étude
-
-
Çankırı
-
Çankırı, Çankırı, Turquie (Türkiye)
- Cankiri Kaatekin University
-
Contact:
- fahriye s kara
- Numéro de téléphone: +90 539 210 49 71
- E-mail: 248426003@ogrenci.karaetin.edu.tr
-
Chercheur principal:
- fahriye s kara
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Be a second-year nursing student in the Department of Nursing at Çankırı Karatekin University
- Be able to speak and understand Turkish
- Have no diagnosed psychiatric disorders
- Have no communication difficulties
- Agree to participate in laughter therapy sessions
- Have no history of using psychotropic medications, either currently or in the past
Exclusion Criteria:
- Failure to attend all laughter therapy sessions
- Having a physical condition that would prevent participation in laughter therapy sessions
- Having previously participated in laughter therapy
- Using medication or another nonpharmacological method to reduce stress
- Having difficulty performing breathing exercises
- Not volunteering to participate in the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Groupe témoin sans intervention
|
|
|
Expérimental: Laughter Therapy Group
|
Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. The days and times for the laughter therapy sessions to be conducted with the experimental group will be planned in consultation with the students. The sessions will be held in a suitable classroom or conference room with the participants seated in a U-shaped arrangement. During the first session, students will receive a brief introduction and information about the activities to be conducted throughout the session. Each session aims to encourage spontaneous laughter by incorporating breathing exercises, rhythmic clapping and vocal exercises, playful and energetic games, "icebreaker laughter," and guided meditation. Each session is scheduled to last approximately 40 minutes. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in quality of life measured by the 12-item Quality of Life Scale
Délai: Baseline (before the intervention) and immediately after completion of the intervention
|
The scale was developed by Ware et al. in 1995. A validity and reliability study conducted by Soylu and Kütük in 2002 demonstrated that it is a measurement tool with adequate psychometric properties for assessing general health status and health-related quality of life in clinical practice and scientific research. The scale comprises 12 items across eight sub-dimensions: physical functioning (2 items), physical role (2 items), bodily pain (1 item), general health (1 item), energy (1 item), social functioning (1 item), emotional role (2 items) and mental health (2 items). Items relating to physical and emotional roles are answered on a dichotomous basis (yes or no), whilst the other items are measured on a Likert scale ranging from 3 to 6. A score of 100 on the scale indicates the best state of health, whilst a score of 0 indicates the worst state of health. In the Turkish validity and reliability study, the Cronbach's alpha coefficient was determined to be between 0.92 and 0.88. |
Baseline (before the intervention) and immediately after completion of the intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in psychological well-being measued by the 8-item Psychological Well-being Scale
Délai: Baseline (before the intervention) and immediately after completion of the intervention
|
The scale identifies key elements of human functioning, ranging from positive relationships to feelings of competence and leading a meaningful and purposeful life. It was developed by Diener and colleagues in 2009. The adaptation into Turkish was carried out by Telef in 2011. In the reliability study of the scale, the Cronbach's alpha internal consistency coefficient was calculated as .80 The items on the Psychological Well-being Scale are rated on a scale of 1 to 7, ranging from 'I strongly disagree' (1) to 'I strongly agree' (7). All items are phrased in positive terms. Scores range from 8 to 56. A high score indicates that the individual possesses a wide range of psychological resources and strengths. Although the scale does not provide separate measurements of the various dimensions of well-being, it offers a general overview of positive functioning across different areas that we believe to be important. |
Baseline (before the intervention) and immediately after completion of the intervention
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: fahriye s kara, Çankırı Karatekin University
- Directeur d'études: mevlut karatas, professor, Çankırı Karatekin University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ÇAKÜ-SB-2026-0051
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .